Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Farmers Insurance
Moodys
Cantor Fitzgerald
UBS
QuintilesIMS
Citi
US Department of Justice
Federal Trade Commission
AstraZeneca

Generated: October 22, 2017

DrugPatentWatch Database Preview

Claims for Patent: 8,697,711

« Back to Dashboard

Claims for Patent: 8,697,711

Title:Inhibitors of bruton'S tyrosine kinase
Abstract: Disclosed herein are compounds, including compounds having the structure of Formula (A), (B), (C), and (D), as described in further detail herein, that form covalent bonds with Bruton's tyrosine kinase (Btk). Also described are irreversible inhibitors of Btk. Methods for the preparation of the compounds are disclosed. Also disclosed are pharmaceutical compositions that include the compounds. Methods of using the Btk inhibitors are disclosed, alone or in combination with other therapeutic agents, for the treatment of autoimmune diseases or conditions, heteroimmune diseases or conditions, cancer, including lymphoma, and inflammatory diseases or conditions.
Inventor(s): Honigberg; Lee (San Francisco, CA), Verner; Erik (Belmont, CA), Pan; Zhengying (Austin, TX)
Assignee: Pharmacyclics, Inc. (Sunnyvale, CA)
Application Number:13/479,053
Patent Claims: 1. A compound having the structure: ##STR00057##

2. A pharmaceutical composition comprising a pharmaceutically acceptable excipient and a compound having the structure: ##STR00058##

3. A compound having the structure: ##STR00059##

4. A pharmaceutical composition comprising a compound of claim 3 and a pharmaceutically acceptable excipient.

5. A process for the preparation of (R)-tert-butyl 3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin- e-1-carboxylate (intermediate 3, R-isomer) comprising coupling of intermediate 2 and (S)-tert-butyl 3-hydroxypiperidine-1-carboxylate: ##STR00060## under Mitsunobu reaction conditions to give intermediate 3 (R-isomer): ##STR00061##

6. The process of claim 5, wherein the process comprises coupling of intermediate 2 and (S)-tert-butyl 3-hydroxypiperidine-1-carboxylate in the presence of diisopropyl azodicarboxylate and polymer-bound triphenylphosphine in tetrahydrofuran.

7. A process for the preparation of (R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)pi- peri-din-1-yl)prop-2-en-1-one (compound 13) comprising treating intermediate 3 (R-isomer) of claim 5 with an acid and then a base, followed by coupling with acryloyl chloride to give compound 13: ##STR00062##

8. A process for the preparation of (S)-tert-butyl 3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin- e-1-carboxylate (intermediate 3, S-isomer) comprising coupling of intermediate 2 and (R)-tert-butyl 3-hydroxypiperidine-1-carboxylate: ##STR00063## under Mitsunobu reaction conditions to give intermediate 3 (S-isomer): ##STR00064##

9. The process of claim 8, wherein the Mitsunobu reaction conditions comprises coupling of intermediate 2 and (R)-tert-butyl 3-hydroxypiperidine-1-carboxylate in the presence of diisopropyl azodicarboxylate and polymer-bound triphenylphosphine in tetrahydrofuran.

10. A process for the preparation of (S)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)pi- peri-din-1-yl)prop-2-en-1-one (compound 14) comprising treating intermediate 3 (S-isomer) of claim 8 with an acid and then a base, followed by coupling with acryloyl chloride to give compound 14: ##STR00065##

11. A process for the preparation of tert-butyl 3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin- e-1-carboxylate (intermediate 3) comprising coupling of intermediate 2 and tert-butyl 3-hydroxypiperidine-1-carboxylate: ##STR00066## under Mitsunobu reaction conditions to give intermediate 3: ##STR00067##

12. The process of claim 11, wherein the Mitsunobu reaction conditions comprises coupling of intermediate 2 and tert-butyl 3-hydroxypiperidine-1-carboxylate in the presence of diisopropyl azodicarboxylate and polymer-bound triphenylphosphine in tetrahydrofuran.

13. A process for the preparation of 1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperi- -din-1-yl)prop-2-en-1-one (compound 4) comprising treating intermediate 3 of claim 11 with an acid and then a base, followed by coupling with acryloyl chloride to give compound 4: ##STR00068##
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Merck
Medtronic
McKesson
Baxter
Harvard Business School
McKinsey
Mallinckrodt
Boehringer Ingelheim
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot